Aberra Faten N, Lichtenstein Gary R
Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Inflamm Bowel Dis. 2005 Jul;11(7):685-95. doi: 10.1097/01.mib.0000160742.91602.b7.
Infections have been reported in patients with inflammatory bowel disease (IBD), especially in association with anti-inflammatory and immunomodulatory medications used to treat IBD. Unfortunately, there is a dearth of information on infectious complication risk in patients with IBD. This review describes infectious complications reported in patients with IBD and provides a framework for future studies to assess potential risk factors and incidence for infection. Recommendations are also provided for prevention of infection.
炎症性肠病（IBD）患者中已报告有感染情况，尤其是与用于治疗IBD的抗炎和免疫调节药物相关的感染。不幸的是，关于IBD患者感染并发症风险的信息匮乏。本综述描述了IBD患者中报告的感染并发症，并为未来评估潜在风险因素和感染发生率的研究提供了一个框架。还提供了预防感染的建议。
